Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Avalyn Pharma Inc.

NASDAQ: AVLN · Life Sciences · 4 alerts · CIK 1540171

Share price
$29.76Close, Nov 16
Market cap
$1.32B
Shares outstanding
44.33MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Avalyn Pharma Inc. filings on SEC EDGAR ↗

4:13 PM ET 8-K
Leadership Change

Avalyn Pharma Leadership Change

Avalyn Pharma Inc. appointed Robert Meyer, M.D. to its Board of Directors as a Class II director, effective September 15, 2026. Dr. Meyer, a former FDA director and Merck executive, brings extensive regulatory and clinical experience to the board. He will receive an annual cash retainer of $40,000 and an initial grant of options to purchase 31,182 shares of common stock.

Counterparty
Robert Meyer, M.D.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.